Starsource Multitrade (506365) Q4 02/03 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 02/03 earnings summary
21 Oct, 2026Executive summary
Factory lockout continued throughout FY2002-03, in place since 28 Nov 1997; no manufacturing or trading activity, and leasing/licensing discussions for plant and machinery were underway.
FY2002-03 net loss was Rs.863,221; accumulated loss carried forward reached Rs.24,796,882.
Financial highlights
Income was Rs.904 versus Rs.274,749 in FY2001-02; expenses were Rs.510,419 versus Rs.7,631,827, including Rs.7,000,000 in trading-share stock expenditure in the prior year.
Depreciation was Rs.353,706; loss before and after tax was Rs.863,221, with no tax provision shown.
Cash and bank balances rose to Rs.237,022 from Rs.212,279; operating cash flow was Rs.299,743 versus an outflow of Rs.171,872.
Outlook and guidance
Leasing or licensing part of the existing plant and machinery to chemical manufacturers was being explored; prospective manufacturers had been identified and negotiations were in progress.
Latest events from Starsource Multitrade
- Tax write-back lifted net profit as factory operations restarted and Fine Chemicals trials advanced.506365
Q4 96/97 - A continuing factory lockout and Rs. 83,23,334 pre-tax loss defined the year.506365
Q4 97/98 - Continued lockout, Rs.4.488m net loss, and major unprovided liabilities and investment impairment.506365
Q4 98/99 - Lockout and a widening Rs.4.38m loss drove plans to explore disposal or leasing.506365
Q4 04/05 - Manufacturing ceased after asset sales; diversification and material financial risks remain.506365
Q4 06/07 - Manufacturing stayed halted; FY08 PAT fell to Rs 0.08 lakh as diversification remained uncertain.506365
Q4 07/08 - Suspended manufacturing, falling income and auditor-flagged asset and loan risks defined FY10.506365
Q4 09/10 - A modest return to profit amid suspended operations, material audit concerns, and suspended share trading.506365
Q4 10/11 - Investment-sale income drove FY12 profit as manufacturing remained suspended.506365
Q4 11/12